Also published in EurekAlert! Science News Releases:
Yale Studies Suggest New Path for Reversing Type-2 Diabetes and Liver Fibrosis
x hide permanently

First FDA-Approved Drug for Thyroid Eye Disease Effective Regardless of Age, Gender

EurekAlert! Science News Releases

EurekaAlert.org

WASHINGTON--Teprotumumab, the first FDA-approved medicine for thyroid eye disease, provides significant improvement in eye-bulging, regardless of patient gender, age or smoking status, according to a study accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.

Though it is a rare condition, thyroid eye disease is devastating to those who have it, affecting their relationships with family, friends, and co-workers. Until recently, no medicine was approved by the U.S. Food and Drug Administration for the treatment of thyroid eye disease. Teprotumumab ...